PLOS ONE 润色咨询

PLoS One

出版年份：2006 年文章数：239709 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：6.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2019-10-16 Derek6456

    这么好投，为什么拒绝我TT

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2022-03-19 Dr Z

    审稿速度:3.0
    偏重的研究方向：针灸;康复
    经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2023-12-03 ms2000001891239095 来自辽宁省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？

    7

    展开7条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2024-05-01 ms3000001775227501 来自福建省

    PLOS ONE投稿一个月，一直都是Under Review，请问什么情况

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2024-06-01 ms9000000969803570 来自江苏省

    ur十天就dip了，是不是要拒稿😵‍💫

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2024-01-11 ms9000000605981017 来自山东省

    这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2024-05-24 接收吧！ 来自吉林省

    各位好人，PubMed能检索出版后，大概多久能在wos检索到呢

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2023-10-27 ms5000001328224209 来自黑龙江省

    2月21日投稿
    7月25日返审稿意见，大修
    9月8日提交修改稿+回答审稿人意见
    9月26日接收
    10月10日改格式，校稿
    10月21日交版面费
    10月26日见刊

    7

    展开7条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2024-05-03 ms8000002098041036 来自河北省

    偏重的研究方向：肿瘤
    经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=578005, encodeId=a75c5e8005c2, content=这么好投，为什么拒绝我TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44e75077324, createdName=Derek6456, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204213, encodeId=7e811204213b1, content=审稿速度:3.0<br>偏重的研究方向：针灸;康复<br>经验分享：截止2022年3月19日，再有两天就3个月了，一直under review。期间催过一次稿，编辑说已经有一名专家愿意接受审稿，但是距离今天又已将近1个月了。不知道什么时候能有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Sat Mar 19 22:34:54 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：3月末投稿，6月初有反馈，major revision, 改完了居然就接受了，发的meta，话说这个期刊水么？是不是预警过？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201358, encodeId=efcf2201358d5, content=PLOS ONE投稿一个月，一直都是Under Review，请问什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Wed May 01 10:45:31 CST 2024, time=2024-05-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207815, encodeId=75f7220e81594, content=ur十天就dip了，是不是要拒稿😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d568220824, createdName=ms9000000969803570, createdTime=Sat Jun 01 21:01:27 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180796, encodeId=91582180e96cf, content=这个杂志收不收综述啊，不是mate或者生信的那种，纯总结性的那种, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ba9097098, createdName=ms9000000605981017, createdTime=Thu Jan 11 15:43:36 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206415, encodeId=b1fc22064159e, content=各位好人，PubMed能检索出版后，大概多久能在wos检索到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8829129489, createdName=接收吧！, createdTime=Fri May 24 13:24:19 CST 2024, time=2024-05-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见，大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式，校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2201632, encodeId=549022016321e, content=偏重的研究方向：肿瘤<br>经验分享：这个杂志收不收纯生信啊？已经投稿一个月了还是under review，有可能被拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Fri May 03 15:41:35 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=912564, encodeId=3d20912564a4, content=这个是SCI嘛，我看是SCIE，不知道国内咋算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ca5285715, createdName=148517d2m93(暂无昵称), createdTime=Thu Dec 31 14:55:19 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2020-12-31 148517d2m93(暂无昵称)

    这个是SCI嘛，我看是SCIE，不知道国内咋算

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分